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Background: In Ethiopia where there is no strong surveillance system and diagnostic facilities are limited, the real
burden of tuberculosis (TB) lymphadenitis is not well known. Therefore, we conducted a study to estimate the
prevalence of TB lymphadenitis in Southwest Ethiopia.
Methods: A community based cross-sectional study was conducted from February to March 2009 in the Gilgel
Gibe field research area. A total of 30,040 individuals 15 years or older in 10,882 households were screened for TB
lymphadenitis. Any individual 15 years or older with lumps in the neck, armpits or groin up on interview were
considered TB lymphadenitis suspect. The diagnosis of TB lymphadenitis was established when acid fast bacilli
(AFB) smear microscopy of fine needle aspiration (FNA) sample, culture or cytology suggested TB. HIV counseling
and testing was offered to all TB lymphadenitis suspects. Descriptive and bivariate analysis was done using
SPSS version 15.
Results: Complete data were available for 27,597 individuals. A total of 87 TB lymphadenitis suspects were
identified. Most of the TB lymphadenitis suspects were females (72.4%). Sixteen cases of TB lymphadenitis were
confirmed. The prevalence of TB lymphadenitis was thus 58.0 per 100,000 people (16/27,597) (95% CI 35.7-94.2).
Individuals who had a contact history with chronic coughers (OR 5.58, 95% CI 1.23-25.43) were more likely to
have TB lymphadenitis. Lymph nodes with caseous FNA were more likely to be positive for TB lymphadenitis (OR
5.46, 95% CI 1.69-17.61).
Conclusion: The prevalence of TB lymphadenitis in Gilgel Gibe is similar with the WHO estimates for Ethiopia.
Screening of TB lymphadenitis particularly for family members who have contact with chronic coughers is
recommended. Health extension workers could be trained to screen and refer TB lymphadenitis suspects using
simple methods.
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TB lymphadenitis is the most common form of extrapul-
monary TB [1]. Its epidemiology and diagnostic aspects
vary according to the patients’ geographic origin and the
burden of TB and HIV infection [2]. Globally the inci-
dence of all forms of TB is decreasing. However, the rate* Correspondence: gemeda.abebe@ju.edu.et
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reproduction in any medium, provided the oris not similar across all WHO regions. In the Africa re-
gion it is decreasing slowly by 1.8% per year [3].
Ethiopia is among the 22 high TB burden countries in
the world. The proportion of extrapulmonary TB among
newly diagnosed TB patients has been increasing for the
last two decades [3]. The WHO and the Ethiopian TB
control program estimate that the proportion of extra-
pulmonary TB among the total number of new TB cases
(156,928) is about 32% [4,5]. The majority of extrapul-
monary TB cases present with TB lymphadenitis. How-
ever, the real burden of pulmonary TB and
extrapulmonary TB in Ethiopia is not known atLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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low quality health services might contribute to low case
detection rates [6]. In the absence of a strong surveil-
lance system and well established diagnostic facilities,
community-based prevalence studies are good alterna-
tives to estimate the burden of disease. We performed
such a study in Southwest Ethiopia to estimate the bur-
den of TB lymphadenitis. To our knowledge, this is the
first community-based prevalence survey for TB lymph-
adenitis in Ethiopia.
Methods
Study design, setting and period
This community-based cross sectional study was con-
ducted from February to March 2009 in Gilgel Gibe
Field Research area (Figure 1) which is located in Jimma
Zone about 260 kilometers Southwest of Addis Ababa
around the reservoir of Gilgel Gibe hydroelectric dam.
The site consists of four districts (locally known as Wor-
edas): Sokoru, Omo Nada, Tiro Afata and Qarsa. Two
small towns and eight rural Kebeles (smallest administra-
tive units), situated within 10 kilometers of the reservoir
of the dam were selected as field research site by Jimma
University in 2005. Since then, regular demographic and
AIDS mortality surveillances have been undertaken byFigure 1 Map of Gilgel Gibe filed research area.Jimma University in the research site. At the time of the
study, the total population of the field research area was
50,156 individuals in 10,882 households.Study population and data collection procedures
At the time of the study the total number of individuals
15 years or older in the study area was 30,040. A ques-
tionnaire was prepared in Amharic (local language) to
identify TB lymphadenitis suspects in the study area.
Trained personnel with high school education visited
each household. If the heads of the households were not
available during the visit, the data collectors repeatedly
visited the same household up to 3 times. Individuals
were asked if they had noticed lumps and bumps in the
neck, armpits or groin themselves. Only those that re-
spond positively were considered suspects and asked to
come the next day to a center to undergo FNA. At the
center those TB lymphadenitis suspects were inter-
viewed using a structured questionnaire including ques-
tions about his/her socio-demographic situation.Sample collection and processing
The FNA was performed by the study pathologists. The
diagnosis of TB lymphadenitis was made when smear
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vidually or in combination.
FNA
FNA was performed using a 22-gauge needle attached to
a 10-cc syringe. The aspirates were macroscopically eval-
uated for caseation. Two smears were prepared from
each aspirate and air dried on site. The remainder of the
aspirate was washed into 1 ml physiological saline for
culture and transported to Jimma University Specialized
Hospital in a cold box. FNA samples were kept at −20°C
till transported in cold box by postal system to Armauer
Hansen Research Institute (AHRI) in Addis Ababa for
culture. All samples were transported within a maximum
of 5 days.
One slide of a smear was stained with the Ziehl-
Neelsen method [7] and examined for the presence of
AFB by an experienced laboratory technician. The sec-
ond smear was stained with Wright stain and cytological
analysis was done by the study pathologists at Jimma
University. TB lymphadenitis diagnosis by cytology was
made by observation of the presence of epitheloid cell
granulomas and caseous necrosis with or without Lan-
ghan’s giant cells [8,9].
Culture
At the AHRI, the FNA samples were processed by the
standard N-acetyl L-cysteine (NALC)-NaOH method
[10] and concentrated at 3000 × g for 15 minutes. The
sediment was reconstituted to 2.5 ml with phosphate
buffer pH 6.8, to make the inoculums for the cultures.
Two Lowenstein-Jensen slants, one containing 0.75%
glycerol and the other containing 0.6% pyruvate, were
inoculated with the sediment and incubated at 37°C.
Cultures were considered negative when no colonies
were seen after 8 weeks of incubation.
HIV Screening
All consenting TB lymphadenitis suspects were tested
for HIV after counseling. Testing for HIV was done as
per Ethiopian national guidelines. HIV screening was
performed using the KHB test (Shanghai Kehua Bio-
Engineering Ltd, Shanghai, China; 2008). A positive sam-
ple was retested using the STAT-PAK test (Chembio
Diagnostic System Inc, Medford, NY, USA; 2008).
Data analysis
Data were double entered using Epi-data version 3.1
(Epi-data, Norway, 2006). For analysis, the data were
exported to SPSS version 15.0 statistical software (SPSS
Inc. Chicago, 2007). Descriptive analysis was done for
the socio-demographic variables and prevalence of TB
lymphadenitis. Logistic regression was done to assess
factors independently associated with TB lymphadenitisin terms of the crude odds ratio and its 95% confidence
interval (CI). A p-value less than or equal to 0.05 was
considered significant.
Ethical consideration
The study was approved by the ethical review commit-
tees of Jimma University, AHRI and the Institute of
Tropical Medicine in Belgium. A workshop was held
with the local community leaders, Kebele chair persons
and Woreda health offices representatives to create
awareness about the purpose of the study. Written con-
sent was obtained from the study participants. First the
head of the house gave consent. Subsequently depending
on the information from the head of the house all the
suspects gave consent before administering the question-
naire and undergoing FNA. New TB cases identified
were immediately referred to the nearby health facility
for treatment.
Results
Characteristics of the TB lymphadenitis suspects
A total of 30,040 individuals 15 years or older in 10,882
households were screened for TB lymphadenitis. Com-
plete data were available from 9 Kelebes (27,597 indivi-
duals 15 years or older) while one Kebele was excluded
from analysis because of incomplete data. After inter-
view 87 TB lymphadenitis suspects were identified. The
mean age (±SD) of the suspects was 33.1 (±11.3) years.
Most (72.4%) were women and married (81.6%). Thirty
one (35.6%) lived in close contact with animals and
45 (53.5%) used to drink raw milk.
Prevalence of TB Lymphadenitis
On the basis of FNA smear microscopy for AFB, cy-
tology and culture 16 (18.4%) of the lymph nodes were
diagnosed as tuberculous. Smears were positive in 2, cul-
ture in 6 and cytology in 13 of the suspects. The micro-
scopic features of FNA cytology of the TB lymphadenitis
showed epithelial histocytes with giant cells in 8 cases,
epithelial histocytes with caseous necrosis in 2 cases and
caseous necrosis alone in 3 cases. Three of these 16
cases were positive by both culture and FNA cytology.
The mycobacteria isolated in 6 cases were identified as
Mycobacterium tuberculosis based on RD typing. The
remaining 10 cases that were negative on culture but
positive on smear and/or cytomorphology were also con-
sidered to be tuberculous. The distribution of TB lymph-
adenitis cases per kebele is indicated in Table 1. The
prevalence of TB lymphadenitis was 58.0 per 100,000
people (16/27,597) (95% CI 35.7-94.2). Other diagnosis
of the lymph nodes include: reactive lymphadenitis (57),
pyogenic lymphadenitis (6), benign mesenchymal neo-
plasia (6) and non-specific lymphadenitis (5).
Table 1 Distribution of TB lymphadenitis cases in the study Kebeles of Gilgel Gibe Field Research Center,
Southwest Ethiopia
Kebele Total population surveyed TB lymphadenitis 95% CI
n (prevalence per 100,000 people)
Siba 2893 1 (34.6) 6.1-195.5
Asandabo 4493 0 (0) 0-85.4
Burka 3539 1 (28.3) 5.0-159.9
Kajelo 3409 2 (58.7) 16.1-213.7
Koticha 2342 1 (42.7) 7.5-241.5
Ayino 3382 2 (59.1) 16.2-215.4
Enkure 2048 3 (146.5) 49.8-429.8
Bore 2065 0 (0) 0-185.7
Danaba 3426 6 (175.1) 80.3-381.6
CI Confidence interval.
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TB lymphadenitis was more frequent in females (86.5
per 100,000) and age group 35–44 (90.4 per 100,000
people) followed by 45 years or older (71.9 per 100,000
people). The differences in the prevalence of TB lymph-
adenitis with respect to sex and age group were not
statistically significant (Table 2). Other personal charac-
teristics associated with TB lymphadenitis are described
in Table 3. Only contact with a person with chronic
cough was significantly associated with TB lymphadenitis
(OR 5.58, 95% CI 1.23-25.43).
Characteristics of the lymph nodes associated with TB
lymphadenitis
Lypmh node characteristics affecting positivity for tuber-
culous lymphadenitis are described in Table 4. Among
the lymph nodes characteristics only caseous FNA sam-
ples were more likely to be from persons with TB
lymphadenitis (OR 5.46, 95% CI 1.69-17.61).
Discussion
Extrapulmonary TB is a significant health problem
worldwide because of difficulties in its diagnosis and inTable 2 Prevalence of lymphadenopathy and tuberculous lym
Gibe, south west Ethiopia
Variable Total population Lymphadenopathy n(prevalen
Sex
Male 13718 24 (174.9)
Female 13879 63 (453.9)
Age
15-24 10482 16 (152.6)
25-34 7129 30 (420.8)
35-44 4423 28 (633.1)
>= 45 5563 13 (233.7)
OR Odds ratio, CI Confidence interval.monitoring its treatment. The proportion of extrapul-
monary TB among all TB cases varies from country to
country. Of the 22 high burden countries the highest
proportion was reported from Cambodia (34.2%) and
the lowest from China (0.69%) [5]. The extrapulmonary
manifestation of TB is prevalent in 10-34% of non-HIV
cases while it occurs in 50-70% of patients co-infected
with HIV [11]. Ethiopia reports the third highest number
of extrapulmonary TB globally (50,417) [5]. In the
current study, we assessed TB lymphadenitis, the major
form of extrapulmonary TB, in a rural community in
Ethiopia.
In this study the diagnosis of TB lymphadenitis was
established when FNA smear microscopy for AFB, cul-
ture and/or cytology reported positive. In fact cytology
suffers from low number of cells that are all in disper-
sion rather than organized tissue as in biopsies. Never-
theless, cytology is specific when compared against
combined criteria [3].
The prevalence of pulmonary TB was 76.1 per 100,000
people in the same study population during the same
study period [12]. It is higher than the prevalence of TB
lymphadenitis as reported here. TB lymphadenitisphadenitis per 100,000 people by sex and age in Gilegl
ce) TB Lymphadenitis n (prevalence) OR [95% CI]
4 (29.2) 1
12 (86.5) 2.97 [0.97- 9.20]
3 (28.6) 1
5 (70.1) 3.43 [0.89- 13.28]
4 (90.4) 2.37 [0.48- 11.75]
4 (71.9) 1.89 [0.38- 9.34]
Table 3 Characteristics of persons with tuberculous




TB status OR [95% CI]
Positive n (%) Negative n (%)
Sex
Male 4 (16.7) 20 (83.3) 1.18 [0.34-4.1]
Female 12 (19.0) 51 (81.0) 1
Age
15-24 3 (18.8) 13 (81.2) 1
25-34 5 (16.7) 25 (83.3) 0.87 [0.18-4.21]
35-44 4 (14.3) 24 (85.7) 0.72 [0.14-3.73]
>= 45 4 (30.8) 9 (69.2) 1.93 [0.34-10.77]
Occupation
Farmer 11 (19.6) 45 (80.4) 0.69 [0.40- 4.06]
Non-farmer 5 (16.1) 26 (83.9) 1
Monthly income
<=400 birr (<=34 USD) 10 (21.3) 37 (78.7) 1.35 [0.14- 12.92]
>400 birr (>34 USD) 1 (16.7) 5 (83.3) 1
Contact with a chronic cougher
Yes 4 (50.0) 4 (50.0) 5.58 [1.23- 25.43]*
No 12 (15.2) 67 (84.8) 1
Contact with cattle
Yes 6 (19.4) 25 (80.6) 1.10 [0.36- 3.39]
No 10 (17.9) 46 (82.10) 1
Drink uncooked milk
Yes 10 (21.3) 37 (78.7) 1.53 [0.50- 4.67]
No 6 (15.0) 34 (85.0) 1
OR Odds ratio, CI Confidence interval, USD United Sates Dollar, *p< 0.05.
Table 4 Characteristics of the lymph nodes in persons
with tuberculous and non-tuberculous lymphadenitis,
Gilgel Gibe, southwest Ethiopia
Characteristic of the
lymph node
TB status OR [95% CI]
Positive n (%) Negative n (%)
Duration
<=6 weeks 8 (25.0) 24 (75.0) 2.28 [0.71- 7.36]
7-12 weeks 2 (25.0) 6 (75.0) 2.28 [0.37- 14.0]
>12 weeks 6 (12.8) 41 (87.2) 1
Tenderness
Tender 2 (18.2) 9 (81.8) 0.98 [0.19- 5.07]
Non-tender 14 (18.4) 62 (81.6) 1
Number of lymph nodes
Single 5 (12.2) 36 (87.80) 1
Few 2 (20.0) 8 (80.0) 1.80 [0.30- 11.0]
Multiple 9 (25.0) 27 (75.0) 2.40 [0.72- 8.0]
Size
1-4 cm 11 (15.5) 60 (84.5) 1
5-10 cm 5 (31.2) 11 (68.8) 2.48 [0.30- 11.0]
Mobility
Mobile 15 (21.4) 55 (78.6) 1
Non-mobile 1 (5.9) 16 (94.1) 0.23 [0.03- 1.87]
Condition
Soft 4 (17.4) 19 (82.6)
Firm 10 (16.9) 49 (83.1)
Matted 2 (66.7) 1 (33.3)
Draining sinus 0 (0.0) 1 (100.0)
Fluctuant 0 (0.0) 1 (100.0)
Lymph node involved
Cervical 12 (18.5) 53 (81.5) 1
Axiliary 3 (27.3) 8 (72.7) 1.66 [0.38- 7.19]
Inguinal 1 (11.1) 8 (88.9) 0.55 [0.06- 4.84]
Others 0 (0.0) 2 (100.0)
Nature of FNA specimen
Caseous 8 (42.1) 11 (57.9) 1
Non-caseous 8 (11.8) 60 (88.2) 5.46 [1.69- 7.61]*
OR Odds ratio, CI Confidence interval, *p< 0.05.
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TB diagnosed in the study setting. A previous report
from Ethiopia also indicated that TB lymphadenitis
accounted for 40% of total TB cases in a rural health
center [13]. WHO estimates for Ethiopia that extrapul-
monary TB accounts for roughly one third of the new
cases of TB in the country [5]. However, it is not pos-
sible to compare the findings from our study with the
national figure of the WHO estimates because of two
main reasons. First, the WHO data were derived from
health institution based reports. Second, our study did
not investigate all forms of extrapulmonary TB. Investi-
gating the different parameters to identify risk factors
for TB lymphadenitis in areas of high and low propor-
tions in the country is recommended.
It has been reported that TB case detection remains
very low in Ethiopia [14]. Indeed, in our study all the TB
lymphadenitis cases were newly diagnosed. The efforts
to improve TB case detection in the country should bestrengthened. It is logical that the health care seeking
behavior could be low for TB lymphadenitis compared
with that of pulmonary TB. This is mainly because pul-
monary TB has a higher case fatality rate than TB
lymphadenitis and the latter is mainly of cosmetic con-
cern at least initially, which takes lower priority in rural
communities with poor access to health facilities. Never-
theless, the health extension workers should be trained
to identify not only pulmonary but also extrapulmonary
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facilities.
A contact history with a chronic cougher was highly
related with the odds of having TB lymphadenitis. This
partly indicates that there is transmission going on in
the community although further study may be needed to
unravel the transmission dynamics. Moreover, this might
indicate that the route of acquisition of lymph node TB
is probably the same as pulmonary and can partly ex-
plain why Mycobacterium bovis was not detected. Other
studies have reported a predominance of Mycobacterium
tuberculosis in TB lymphadenitis in Ethiopia [15,16] al-
though bovine transmission would be expected where
raw milk is consumed.
Cervical lymph nodes were the prominent sites
involved in our study supporting previous reports [17–
19]. Studies have reported that women were more likely
to be positive for TB lymphadenitis compared with men
[20–25]. Moreover, it has been suggested that in male
dominated communities, where women experience
poorer living conditions, young females generally notice
differences in their appearance earlier than males [26].
In our study, however, the rate of TB lymphadenitis was
not significantly different between the two sexes. Our
previous finding from the study area on health seeking
behavior also did not find a difference in gender [27].
The age group 35–44 years and FNA samples from axil-
lary lymph nodes has shown the largest proportion of
cases but difference in prevalence in terms of age group
and location of the lymphnodes was not statistically
significant.
Previous studies have suggested that the extrapulmon-
ary forms of TB could be attributed to HIV co infection
[18,28]. In Ethiopia the HIV prevalence for rural areas
was estimated to be 0.9% [29]. However, in our case all
the TB suspects were HIV negative. This suggests that
apart from HIV either mycobacterial strains or host fac-
tors may play an important role in TB lymphadenitis in
this community. Recent reports elsewhere identified that
single nucleotide polymorphisms rs4893980 on gene
PDE11A of chromosome number 2, rs10488286 on gene
KCND2 of chromosome number 7 and rs2026414 on
gene PCDH15 of chromosome number 10 in humans
were associated with extrapulmonary tuberculosis [30].
In this study we did not do the typing for host genetic
factors predisposing for TB lymphadenitis.
The strength of our study was that it has tried to ad-
dress the neglected component of TB at community
level. However, our study was not without pitfalls. We
probably underestimated the prevalence of tuberculous
lymphadenopathies because individuals were not system-
atically examined for lymphadenopathies and culturing
of the samples were delayed due to transport problems.
Moreover, the methods that we used for the laboratorydiagnosis of lymph node TB are not the most sensitive
and specific. We did not use PCR which may have high
sensitivity in detection of lymph node TB [31]. These all
limitations in combination may have resulted in under
estimation of the lymph node TB prevalence in commu-
nities living in Gilgel Gibe research site.
Conclusions
The prevalence of TB lymphadenitis was 58 per 100,000
people in Gilgel Gibe. Screening of TB lymphadenitis
particularly for family members who have contact with
chronic coughers is recommended. Health extension
workers could be trained to screen and refer TB lymph-
adenitis suspects using simple methods.
Competing interest
The authors declared that there is no competing interest.
Acknowledgments
The authors appreciate the study participants for their cooperation in
providing the necessary samples and information. The study was funded by
the Directorate General for Development Cooperation (DGDC) through the
Flemish Interuniversity Council (VLIR-UOS).
Author details
1Department of Medical Laboratory Sciences and Pathology, Jimma
University, Jimma, Ethiopia. 2Department of Epidemiology, Jimma University,
Jimma, Ethiopia. 3Department of Clinical Sciences, Institute of Tropical
Medicine, Antwerp, Belgium. 4Department of Internal Medicine, Jimma
University, Jimma, Ethiopia. 5Department of Psychiatry, Jimma University,
Jimma, Ethiopia. 6Department of Health Service Management, Jimma
University, Jimma, Ethiopia. 7Armauer Hansen Research Institute, Addis
Ababa, Ethiopia. 8Department of Epidemiology and Social Medicine,
University of Antwerp, Antwerp, Belgium.
Authors’ contribution
GA was involved in the conception and design of the study, coordinated the
field work, analyzed the data and drafted the manuscript. AD was involved
in the conception, design of the study, field work and review of the article.
LA was involved in the design and reviewed the article. AA, FD, KW, CJ, MT,
JS, AAseffa and MB participated in the design, field work and reviewed the
article. MB and AB participated in lab work and reviewed the article. RC
participated in the design, critically reviewed and approved the article. All
authors read and approved the final manuscript.
Received: 19 February 2012 Accepted: 6 July 2012
Published: 6 July 2012
References
1. Ilgazli A, Boyaci H, Basyigit I, Yildiz F: Extrapulmonary tuberculosis: clinical
and epidemiologic spectrum of 636 cases. Arch Med Res 2004, 35:435–441.
2. Weis SE, Moonan PK, Pogoda JM, Turk L, King B, Freeman-Thompson S,
Burgess G: Tuberculosis in the foreign-born population of Tarrant county,
Texas by immigration status. Am J Respir Crit Care Med 2001, 164:953–957.
3. Iwnetu R, van den Hombergh J, Woldeamanuel Y, Asfaw M, Gebrekirstos C,
Negussie Y, Bekele T, Ashenafi S, Seyoum B, Melaku K, et al: Is tuberculous
lymphadenitis over-diagnosed in Ethiopia? Comparative performance of
diagnostic tests for mycobacterial lymphadenitis in a high-burden
country. Scand J Infect Dis 2009, 41:462–468.
4. Tesgaye F: Status of TB control programs in Ethiopia. In Fifth National
Tuberculosis Workshop. Jimma University: TRAC, JU; 2009.
5. World Health Organization: WHO Report 2011: Global tuberculosis control
2011. Geneva: World Health Organization; 2011.
6. Federal Ministry of Health Ethiopia: TB, leprosy and TB/HIV prevention and
control program manual. 4th edition. Addis Ababa:; 2007.
Abebe et al. BMC Public Health 2012, 12:504 Page 7 of 7
http://www.biomedcentral.com/1471-2458/12/5047. International Union Against Tuberculosis and Lung Disease: Sputum
examination for tuberculosis by direct microscopy in low income countries. 5th
edition. Paris: IUATLD; 2000.
8. Verma K, Kapila K: Aspiration cytology for diagnosis of tuberculosis–
perspectives in India. Indian J Pediatr 2002, 69(Suppl 1):S39–43.
9. Bezabih M, Mariam DW: Determination of aetiology of superficial
enlarged lymph nodes using fine needle aspiration cytology. East Afr
Med J 2003, 80:559–563.
10. Cruciani M, Scarparo C, Malena M, Bosco O, Serpelloni G, Mengoli C: Meta-
analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid
media, for detection of mycobacteria. J Clin Microbiol 2004, 42:2321–2325.
11. Ozvaran MK, Baran R, Tor M, Dilek I, Demiryontar D, Arinc S, Toker N,
Chousein EU, Sogukpinar O: Extrapulmonary tuberculosis in non-human
immunodeficiency virus-infected adults in an endemic region. Ann
Thorac Med 2007, 2:118–121.
12. Deribew A, Abebe G, Apers L, Abdisa A, Deribe F, Woldemichael K, Jira C,
Tesfaye M, Shiffa J, Assefa A, et al: Prevalence of pulmonary TB and
spoligotype pattern of Mycobacterium tuberculosis among TB suspects
in a rural community in Southwest Ethiopia. BMC Infect Dis 2012, 12:54.
13. Yassin MA, Olobo JO, Kidane D, Negesse Y, Shimeles E, Tadesse A, Demissie
A, Britton S, Harboe M, Aseffa A, Abate G: Diagnosis of tuberculous
lymphadenitis in Butajira, rural Ethiopia. Scand J Infect Dis 2003,
35:240–243.
14. Federal Ministry of Health of Ethiopia: Annual Health Service report. Addis
Ababa:; 2010.
15. Beyene D, Bergval I, Hailu E, Ashenafi S, Yamuah L, Aseffa A, Wiker HG,
Engers H, Klatser P, Sviland L: Identification and genotyping of the
etiological agent of tuberculous lymphadenitis in Ethiopia. J Infect Dev
Ctries 2009, 3:412–419.
16. Tschopp R, Bobosha K, Aseffa A, Schelling E, Habtamu M, Iwnetu R, Hailu E,
Firdessa R, Hussein J, Young D, Zinsstag J: Bovine tuberculosis at a cattle-
small ruminant-human interface in Meskan, Gurage region, Central
Ethiopia. BMC Infect Dis 2011, 11:318.
17. Samaila M, Oluwole OP: Extrapulmonary tuberculosis: fine needle
aspiration cytology diagnosis. Niger J Clin Pract 2011, 14:297–299.
18. Geldmacher H, Taube C, Kroeger C, Magnussen H, Kirsten DK: Assessment
of lymph node tuberculosis in northern Germany: a clinical review. Chest
2002, 121:1177–1182.
19. Morad NA: Tuberculous cervical lymphadenopathy: should
antituberculous therapy be preceded by histological proof? Trop Doct
2000, 30:18–20.
20. Musellim B, Erturan S, Sonmez Duman E, Ongen G: Comparison of extra-
pulmonary and pulmonary tuberculosis cases: factors influencing the
site of reactivation. Int J Tuberc Lung Dis 2005, 9:1220–1223.
21. Sreeramareddy CT, Panduru KV, Verma SC, Joshi HS, Bates MN: Comparison
of pulmonary and extrapulmonary tuberculosis in Nepal- a hospital-
based retrospective study. BMC Infect Dis 2008, 8:8.
22. Chandir S, Hussain H, Salahuddin N, Amir M, Ali F, Lotia I, Khan AJ:
Extrapulmonary tuberculosis: a retrospective review of 194 cases at a
tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc 2010,
60:105–109.
23. Ullah S, Shah SH, Aziz ur R, Kamal A, Begum N, Khan G: Extrapulmonary
tuberculosis in Lady Reading Hospital Peshawar, NWFP, Pakistan: survey
of biopsy results. J Ayub Med Coll Abbottabad 2008, 20:43–46.
24. Garcia-Rodriguez JF, Alvarez-Diaz H, Lorenzo-Garcia MV, Marino-Callejo A,
Fernandez-Rial A, Sesma-Sanchez P: Extrapulmonary tuberculosis:
epidemiology and risk factors. Enferm Infecc Microbiol Clin 2011,
29:502–509.
25. Forssbohm M, Zwahlen M, Loddenkemper R, Rieder HL: Demographic
characteristics of patients with extrapulmonary tuberculosis in Germany.
Eur Respir J 2008, 31:99–105.
26. Dandapat MC, Mishra BM, Dash SP, Kar PK: Peripheral lymph node
tuberculosis: a review of 80 cases. Br J Surg 1990, 77:911–912.
27. Abebe G, Deribew A, Apers L, Woldemichael K, Shiffa J, Tesfaye M, Abdissa
A, Deribie F, Jira C, Bezabih M, et al: Knowledge, health seeking behavior
and perceived stigma towards tuberculosis among tuberculosis suspects
in a rural community in southwest Ethiopia. PLoS One 2010, 5:e13339.
28. Barnes PF, Lakey DL, Burman WJ: Tuberculosis in patients with HIV
infection. Infect Dis Clin North Am 2002, 16:107–126.
29. Central Statistical Authority: Ethiopia Demographic and Health Survey 2005.
Addis Ababa EaC: Central Statistical Agency and ORC Macro; 2006:179–199.30. Oki NO, Motsinger-Reif AA, Antas PR, Levy S, Holland SM, Sterling TR: Novel
human genetic variants associated with extrapulmonary tuberculosis: a
pilot genome wide association study. BMC Res Notes 2011, 4:28.
31. Singh KK, Muralidhar M, Kumar A, Chattopadhyaya TK, Kapila K, Singh MK,
Sharma SK, Jain NK, Tyagi JS: Comparison of in house polymerase chain
reaction with conventional techniques for the detection of
Mycobacterium tuberculosis DNA in granulomatous lymphadenopathy. J
Clin Pathol 2000, 53:355–361.
doi:10.1186/1471-2458-12-504
Cite this article as: Abebe et al.: Tuberculosis lymphadenitis in
Southwest Ethiopia: a community based cross-sectional study. BMC
Public Health 2012 12:504.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
